Camptosar
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Dr. Alan Sandler’s sweeping review of the role of irinotecan (CPT-11, Camptosar) in the treatment of small-cell lung cancer (SCLC…
Oral fluoropyrimidines have the potential to simplify and supplant fluorouracil (5-FU)-based combination chemotherapy for…
In the past 5 years, the treatment of metastatic colorectal cancer has seen unparalleled advances. Median overall survivals…
Colon cancer is one of the most common malignancies. In the structure of cancer morbidity in the world, colorectal cancer is…
Gilbert’s syndrome (GS) occurs in approximately 10% of the European population. The most common cause is homozygosity for UGT1A1…
While the top pharmaceutical companies have all made investments at an R&D stage in biomarkers and genetics to aid drug selection…
开普拓是一种有效的、具有代表性的抗肿瘤新药，属于S期特异性的半合成可溶性喜树碱类衍生物。它由日本研制开发，1987年开始Ⅰ期临床试验。为了明确其治疗实体瘤的价值，在全球范围内开展了大量的研究。目前，该药已获得美国食品和药品管理局（FDA…
The FDA has made great strides over the past twenty years in loosening drug approval regulations to speed important, life-saving…
The 4th Investigators’ Workshop sponsored by The University of Texas M. D. Anderson Cancer Center was held on July 25-29, 2001…